Fig. 3: Silent trial workflow diagram.
From: Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection
In blue, relevant components of the standard clinical workflow are shown along a timeline. ΔT indicates the time from molecular accession to the availability of a result. The silent trial components occurring in parallel with the clinical workflow are indicated in green.
